CWGFX | FTGFX | CWGFX / FTGFX | |
Total Expense Ratio | 0.80 | 0.74 | 108% |
Annual Report Gross Expense Ratio | 0.80 | 0.74 | 108% |
Fund Existence | 24 years | 12 years | - |
Gain YTD | 16.082 | 16.825 | 96% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 137B | 9.07B | 1,511% |
Annual Yield % from dividends | 1.42 | 1.03 | 138% |
Returns for 1 year | 10.59 | 11.16 | 95% |
Returns for 3 years | 49.40 | 51.42 | 96% |
Returns for 5 years | 44.04 | 51.00 | 86% |
Returns for 10 years | 74.44 | 45.27 | 164% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIS | 14.38 | 0.11 | +0.80% |
ProShares UltraShort Nasdaq Biotech | |||
STXI | 29.49 | 0.09 | +0.30% |
Strive International Developed Mkts ETF | |||
ETW | 8.95 | 0.02 | +0.22% |
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund | |||
FLTB | 50.68 | 0.10 | +0.20% |
Fidelity Limited Term Bond ETF | |||
NUAG | 21.14 | 0.03 | +0.17% |
Nuveen Enhanced Yield US Aggt Bd ETF |